Francisco J. Hernandez‐Ilizaliturri
Roswell Park Comprehensive Cancer Center
ORCID: 0000-0001-8054-3539Also affiliated with University at Buffalo, State University of New York
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Results of the DIAL study (NCI 10089), a randomized phase 2 trial of varlilumab combined with nivolumab in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (r/r B-NHL).”.
Justin Kline, Aleksandr Lazaryan, Nancy L. Bartlett, Francisco J. Hernandez‐Ilizaliturri, Farrukh T. Awan +13 more
Jessica Y. Islam, Cassandra Hennessy, Jun Yang Jiang, Sharad Goyal, Diana Vilar‐Compte +15 more
Chao Xu, Samuel L. Galster, Javier Querol-García, Scott Portwood, Cory Mavis +12 more
Francisco J. Hernandez‐Ilizaliturri, James L. Clements, Myron S. Czuczman, Scott H. Olejniczak
Francisco J. Hernandez‐Ilizaliturri, James L. Clements, Myron S. Czuczman, Scott H. Olejniczak